92 related articles for article (PubMed ID: 17325553)
1. Effect of antireflux treatment on asthma exacerbations in nonatopic children.
Khoshoo V; Haydel R
J Pediatr Gastroenterol Nutr; 2007 Mar; 44(3):331-5. PubMed ID: 17325553
[TBL] [Abstract][Full Text] [Related]
2. Asthmatics with gastroesophageal reflux: long term results of a randomized trial of medical and surgical antireflux therapies.
Sontag SJ; O'Connell S; Khandelwal S; Greenlee H; Schnell T; Nemchausky B; Chejfec G; Miller T; Seidel J; Sonnenberg A
Am J Gastroenterol; 2003 May; 98(5):987-99. PubMed ID: 12809818
[TBL] [Abstract][Full Text] [Related]
3. Therapy with gastric acidity inhibitors increases the risk of acute gastroenteritis and community-acquired pneumonia in children.
Canani RB; Cirillo P; Roggero P; Romano C; Malamisura B; Terrin G; Passariello A; Manguso F; Morelli L; Guarino A;
Pediatrics; 2006 May; 117(5):e817-20. PubMed ID: 16651285
[TBL] [Abstract][Full Text] [Related]
4. A randomised prospective study comparing the effectiveness of esomeprazole treatment strategies in clinical practice for 6 months in the management of patients with symptoms of gastroesophageal reflux disease.
Norman Hansen A; Bergheim R; Fagertun H; Lund H; Moum B
Int J Clin Pract; 2005 Jun; 59(6):665-71. PubMed ID: 15924594
[TBL] [Abstract][Full Text] [Related]
5. [Use of omeprazole and esomeprazole in patients suffering from bronchial asthma with associated gastroesophageal reflux disease].
Maev IV; Viuchnova ES; Balashova NN; Shchekina MI
Eksp Klin Gastroenterol; 2003; (3):26-31, 116. PubMed ID: 14556543
[TBL] [Abstract][Full Text] [Related]
6. Healing of erosive esophagitis and improvement of symptoms of gastroesophageal reflux disease after esomeprazole treatment in children 12 to 36 months old.
Tolia V; Gilger MA; Barker PN; Illueca M
J Pediatr Gastroenterol Nutr; 2010 Nov; 51(5):593-8. PubMed ID: 20706150
[TBL] [Abstract][Full Text] [Related]
7. Frequency of gastroesophageal reflux disease in nonatopic children with asthma-like airway disease.
Yüksel H; Yilmaz O; Kirmaz C; Aydoğdu S; Kasirga E
Respir Med; 2006 Mar; 100(3):393-8. PubMed ID: 16099150
[TBL] [Abstract][Full Text] [Related]
8. Gastroesophageal reflux disease as a cause of death is increasing: analysis of fatal cases after medical and surgical treatment.
Rantanen TK; Sihvo EI; Räsänen JV; Salo JA
Am J Gastroenterol; 2007 Feb; 102(2):246-53. PubMed ID: 17156140
[TBL] [Abstract][Full Text] [Related]
9. [Effectiveness of antireflux therapy in asthmatic children with gastroesophageal reflux disease].
Farcău D; Dreghiciu D; Cherecheş-Panţa P; Popa M; Farcău M; Nanulescu M
Pneumologia; 2004; 53(4):207-11. PubMed ID: 16106733
[TBL] [Abstract][Full Text] [Related]
10. Gastroesophageal reflux disease: new treatments.
Katz PO
Rev Gastroenterol Disord; 2002; 2(2):66-74. PubMed ID: 12122962
[TBL] [Abstract][Full Text] [Related]
11. Omeprazole versus ranitidine or ranitidine/metoclopramide in poorly responsive symptomatic gastroesophageal reflux disease.
Richter JE; Sabesin SM; Kogut DG; Kerr RM; Wruble LD; Collen MJ
Am J Gastroenterol; 1996 Sep; 91(9):1766-72. PubMed ID: 8792695
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the effects of esomeprazole and fundoplication on airway responsiveness in patients with gastro-oesophageal reflux disease.
Kiljander T; Rantanen T; Kellokumpu I; Kööbi T; Lammi L; Nieminen M; Poussa T; Ranta A; Saarelainen S; Salminen P
Clin Respir J; 2013 Jul; 7(3):281-7. PubMed ID: 23006321
[TBL] [Abstract][Full Text] [Related]
13. [GERD (gastroesophageal reflux disease)].
Dobashi K
Nihon Rinsho; 2001 Oct; 59(10):2045-50. PubMed ID: 11676152
[TBL] [Abstract][Full Text] [Related]
14. Laryngopharyngeal reflux: prospective cohort study evaluating optimal dose of proton-pump inhibitor therapy and pretherapy predictors of response.
Park W; Hicks DM; Khandwala F; Richter JE; Abelson TI; Milstein C; Vaezi MF
Laryngoscope; 2005 Jul; 115(7):1230-8. PubMed ID: 15995512
[TBL] [Abstract][Full Text] [Related]
15. The gain in quality-adjusted life months by switching to esomeprazole in those with continued reflux symptoms in primary care: EncomPASS--a cluster-randomized trial.
Moayyedi P; Armstrong D; Hunt RH; Lei Y; Bukoski M; White RJ
Am J Gastroenterol; 2010 Nov; 105(11):2341-6. PubMed ID: 20842110
[TBL] [Abstract][Full Text] [Related]
16. Safety and symptom improvement with esomeprazole in adolescents with gastroesophageal reflux disease.
Gold BD; Gunasekaran T; Tolia V; Wetzler G; Conter H; Traxler B; Illueca M
J Pediatr Gastroenterol Nutr; 2007 Nov; 45(5):520-9. PubMed ID: 18030228
[TBL] [Abstract][Full Text] [Related]
17. Safety and tolerability of esomeprazole in children with gastroesophageal reflux disease.
Gilger MA; Tolia V; Vandenplas Y; Youssef NN; Traxler B; Illueca M
J Pediatr Gastroenterol Nutr; 2008 May; 46(5):524-33. PubMed ID: 18493207
[TBL] [Abstract][Full Text] [Related]
18. Long-term management of patients with symptoms of gastro-oesophageal reflux disease -- a Norwegian randomised prospective study comparing the effects of esomeprazole and ranitidine treatment strategies on health-related quality of life in a general practitioners setting.
Hansen AN; Bergheim R; Fagertun H; Lund H; Wiklund I; Moum B
Int J Clin Pract; 2006 Jan; 60(1):15-22. PubMed ID: 16409423
[TBL] [Abstract][Full Text] [Related]
19. Six-month management of patients following treatment for gastroesophageal reflux disease symptoms -- a Norwegian randomized, prospective study comparing the costs and effectiveness of esomeprazole and ranitidine treatment strategies in a general medical practitioners setting.
Hansen AN; Wahlqvist P; Jørgensen E; Bergheim R; Fagertun H; Lund H; Moum B
Int J Clin Pract; 2005 Jun; 59(6):655-64. PubMed ID: 15924593
[TBL] [Abstract][Full Text] [Related]
20. Bronchial hyperreactivity in non-atopic children with asthma and reflux: effect of anti-reflux treatment.
Khoshoo V; Mohnot S; Haydel R; Saturno E; Edell D; Kobernick A
Pediatr Pulmonol; 2009 Nov; 44(11):1070-4. PubMed ID: 19830719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
